Arighno Das

606 total citations
26 papers, 368 citations indexed

About

Arighno Das is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Arighno Das has authored 26 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 6 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Arighno Das's work include Bladder and Urothelial Cancer Treatments (9 papers), Urinary and Genital Oncology Studies (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Arighno Das is often cited by papers focused on Bladder and Urothelial Cancer Treatments (9 papers), Urinary and Genital Oncology Studies (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Arighno Das collaborates with scholars based in United States, United Kingdom and Brazil. Arighno Das's co-authors include Joshua J. Meeks, Damiano Fantini, Joshua A. Halpern, Robert E. Brannigan, Kimberly A. McLaughlin, Brian J. Jordan, Ahmed Gabr, S. Mouli, Ahsun Riaz and David J. McConkey and has published in prestigious journals such as Journal of Neurochemistry, The Journal of Urology and Annals of Oncology.

In The Last Decade

Arighno Das

24 papers receiving 358 citations

Peers

Arighno Das

SURGE

PRM

ONCOL

EPIDE

Ragna Vanslembrouck Belgium

Jae Woong Choi South Korea

Xiaoyan Xie China

Juliane Liberto United States

Bok Ai Choo Singapore

Nan–Hua Chou Taiwan

Mario Federico Spain

Roberto Almeida Gil Brazil

Maciej Stukan Poland

Ragna Vanslembrouck Belgium

Arighno Das

208 ×1.3

SURGE

80 ×0.8

PRM

106 ×1.1

42 ×0.6

ONCOL

70 ×0.9

EPIDE

Citations per year, relative to Arighno Das Arighno Das (= 1×) peers Ragna Vanslembrouck

Countries citing papers authored by Arighno Das

Since Specialization

Citations

This map shows the geographic impact of Arighno Das's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arighno Das with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arighno Das more than expected).

Fields of papers citing papers by Arighno Das

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arighno Das. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arighno Das. The network helps show where Arighno Das may publish in the future.

Co-authorship network of co-authors of Arighno Das

This figure shows the co-authorship network connecting the top 25 collaborators of Arighno Das. A scholar is included among the top collaborators of Arighno Das based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arighno Das. Arighno Das is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Das, Arighno, Glenn O. Allen, Soroush Rais‐Bahrami, et al.. (2025). Prostate zonal impact of 5α‐reductase inhibitors on multiparametric MRI characteristics and detection of prostate cancer. British Journal of Urology. 137(2). 332–338.

Das, Arighno, Michael Risk, Daniel D. Shapiro, et al.. (2023). Shorter Ureters Lead to Fewer Strictures Following Cystectomy and Urinary Diversion. Urology. 184. 272–277. 1 indexed citations

Karam, José A., Viraj A. Master, Philippe E. Spiess, et al.. (2023). Contemporary Patients Have Better Perioperative Outcomes Following Cytoreductive Nephrectomy: A Multi-institutional Analysis of 1272 Consecutive Patients. Urology. 182. 168–174. 2 indexed citations

Das, Arighno, Daniel D. Shapiro, Juliana Craig, & E. Jason Abel. (2023). Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC. Nature Reviews Urology. 20(11). 654–668. 9 indexed citations

Das, Arighno, et al.. (2022). Biofeedback therapy for children: What is the maximum number of sessions we should offer?. Journal of Pediatric Urology. 19(3). 240.e1–240.e6. 6 indexed citations

Sanderson, Benjamin M., Deborah Enting, Caterina Aversa, et al.. (2022). Using Real-world Data to Define a Validated Nomogram for Advanced Bladder Cancer Patients Who Respond to Immunotherapy. Clinical Oncology. 34(10). 642–652. 5 indexed citations

Morgan, Dane, et al.. (2021). Evaluation of radiomics and machine learning in identification of aggressive tumor features in renal cell carcinoma (RCC). Abdominal Radiology. 46(9). 4278–4288. 12 indexed citations

Gregory, Dyanna L., Amna Daud, Arighno Das, et al.. (2021). Comanagement With Nephrologist Care Is Associated With Fewer Cardiovascular Events Among Liver Transplant Recipients With Chronic Kidney Disease. Transplantation Direct. 7(10). e766–e766. 3 indexed citations

Aversa, Caterina, Arighno Das, Deborah Enting, et al.. (2020). 765P Predicting survival in urothelial cancer patients after immunotherapy using real-world data. Annals of Oncology. 31. S590–S590. 3 indexed citations

10.

Robertson, A. Gordon, Clarice S. Groeneveld, Brian J. Jordan, et al.. (2020). Identification of Differential Tumor Subtypes of T1 Bladder Cancer. European Urology. 78(4). 533–537. 93 indexed citations

11.

Halpern, Joshua A., et al.. (2020). Oncofertility in adult and pediatric populations: options and barriers. Translational Andrology and Urology. 9(S2). S227–S238. 26 indexed citations

12.

Das, Arighno, et al.. (2020). Sperm retrieval success and testicular histopathology in idiopathic nonobstructive azoospermia. Asian Journal of Andrology. 22(6). 555–555. 15 indexed citations

13.

Meeks, Joshua J., Gottfrid Sjödahl, Seth P. Lerner, et al.. (2020). Tumor Subtyping: Making Sense of Heterogeneity with a Goal Toward Treatment. Bladder Cancer. 7(1). 1–11. 5 indexed citations

14.

Podojil, Joseph R., Alexander P. Glaser, Elise T. Courtois, et al.. (2020). Antibody targeting of B7-H4 enhances the immune response in urothelial carcinoma. OncoImmunology. 9(1). 1744897–1744897. 30 indexed citations

15.

Das, Arighno, Ahsun Riaz, Ahmed Gabr, et al.. (2019). Safety and efficacy of radioembolization with glass microspheres in hepatocellular carcinoma patients with elevated lung shunt fraction: analysis of a 103-patient cohort. European Journal of Nuclear Medicine and Molecular Imaging. 47(4). 807–815. 15 indexed citations

16.

Halpern, Joshua A., Arighno Das, & Robert E. Brannigan. (2019). Successful sperm retrieval in prune belly syndrome. Asian journal of urology. 7(4). 376–378. 2 indexed citations

17.

Das, Arighno, Ahmed Gabr, Ahsun Riaz, et al.. (2019). Contemporary Systematic Review of Health-Related Quality of Life Outcomes in Locoregional Therapies for Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology. 30(12). 1924–1933.e2. 13 indexed citations

18.

Das, Arighno, et al.. (2018). P3.15-26 Safety of Nivolumab in Thoracic Malignancies: Results from a Single Institution in Bangladesh. Journal of Thoracic Oncology. 13(10). S1000–S1001.

19.

VanWagner, Lisa B., Samantha Montag, Lihui Zhao, et al.. (2018). Cardiovascular Disease Outcomes Related to Early Stage Renal Impairment After Liver Transplantation. Transplantation. 102(7). 1096–1107. 22 indexed citations

20.

Prados, Michael D., Timothy F. Cloughesy, Meghna Samant, et al.. (2009). 8721 Evaluation of objective response as a predictor of survival in bevacizumab-treated patients with glioblastoma at first or second relapse in the BRAIN Study. European Journal of Cancer Supplements. 7(2). 499–500. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact